2017 Annual Meeting

Session: Amorphous Solid Dispersions for Drug Product

Amorphous solid dispersions enabling formulations for drug product

Chair

Moser, J. D., Merck & Co., Inc.

Co-Chair

Rane, A., Pfizer

Presentations

03:30 PM

(14a) Sustained Supersaturation of Erlotinib Sdd Ternary Amorphous Systems

03:50 PM

(14b) Connecting the Product-Process-Performance Interplay for Improved Understanding in Development of a Spray Dried Dispersion Drug Product

04:10 PM

(14c) Strategically-Designed Polymer Synthons As Pharmaceutical Excipients in Oral Drug Delivery

04:30 PM

(14d) Pill Burden Reduction through Engineering the Mechanical Properties of Spray-Dried Amorphous Solid Dispersions

04:50 PM

(14e) Reprocessing of Spray Dried Dispersions: Minimizing Resources in Process Development and Dealing with the Possible Failure

05:10 PM

(14f) In silico Development of Amorphous Solid Dispersions for Optimal Performance and Stability

05:30 PM

(14g) Experimental and Model-Based Optimization of a Secondary Drying Process for a Spray Dried Dispersion Product